484 related articles for article (PubMed ID: 28647998)
1. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
[No Abstract] [Full Text] [Related]
2. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
[No Abstract] [Full Text] [Related]
3. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.
Habara M; Terashima M; Nasu K; Kaneda H; Yokota D; Ito T; Kurita T; Teramoto T; Kimura M; Kinoshita Y; Tsuchikane E; Asakura Y; Suzuki T
Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):276-84. PubMed ID: 22945378
[TBL] [Abstract][Full Text] [Related]
4. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study.
Habara M; Terashima M; Nasu K; Kaneda H; Inoue K; Ito T; Kamikawa S; Kurita T; Tanaka N; Kimura M; Kinoshita Y; Tsuchikane E; Matsuo H; Ueno K; Katoh O; Suzuki T
Circ Cardiovasc Interv; 2011 Jun; 4(3):232-8. PubMed ID: 21610225
[TBL] [Abstract][Full Text] [Related]
5. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
[TBL] [Abstract][Full Text] [Related]
6. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
[TBL] [Abstract][Full Text] [Related]
7. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
[TBL] [Abstract][Full Text] [Related]
9. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
[TBL] [Abstract][Full Text] [Related]
10. The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.
Sato K; Costopoulos C; Takebayashi H; Naganuma T; Miyazaki T; Goto K; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Ito H; Colombo A; Haruta S
J Cardiol; 2014 Dec; 64(6):488-95. PubMed ID: 24794757
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
[TBL] [Abstract][Full Text] [Related]
13. Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation - An Optical Coherence Tomography Study.
Jinnouchi H; Kuramitsu S; Shinozaki T; Tomoi Y; Hiromasa T; Kobayashi Y; Domei T; Soga Y; Hyodo M; Shirai S; Ando K
Circ J; 2017 Mar; 81(4):450-457. PubMed ID: 28132981
[TBL] [Abstract][Full Text] [Related]
14. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
Araki T; Nakamura M; Sugi K
J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
[TBL] [Abstract][Full Text] [Related]
15. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
Miura K; Tada T; Habara S; Kuwayama A; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Otsuru S; Tanaka H; Fuku Y; Goto T; Kadota K
Circ J; 2018 Oct; 82(11):2820-2828. PubMed ID: 30158345
[TBL] [Abstract][Full Text] [Related]
17. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
EuroIntervention; 2017 Jun; 13(3):294-302. PubMed ID: 28320686
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.
Kang SJ; Mintz GS; Akasaka T; Park DW; Lee JY; Kim WJ; Lee SW; Kim YH; Whan Lee C; Park SW; Park SJ
Circulation; 2011 Jun; 123(25):2954-63. PubMed ID: 21646494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
